Boran, T. Et Al. 2021. Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.. Toxicology letters , vol.336 , 39-49.

Boran, T., Akyildiz, A., Jannuzzi, A. T., & Alpertunga, B., (2021). Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.. Toxicology letters , vol.336, 39-49.

Boran, T Et Al. "Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.," Toxicology letters , vol.336, 39-49, 2021

Boran, T Et Al. "Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.." Toxicology letters , vol.336, pp.39-49, 2021

Boran, T. Et Al. (2021) . "Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.." Toxicology letters , vol.336, pp.39-49.

@article{article, author={T Boran Et Al. }, title={Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.}, journal={Toxicology letters}, year=2021, pages={39-49} }